This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Bausch + Lomb Ireland Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Michael Mutz: Innovator in Ocular Treatments
Introduction
Michael Mutz is a notable inventor based in Freiburg im Breisgau, Germany. He has made significant contributions to the field of ocular treatments through his innovative research and development. His work focuses on improving the quality of life for individuals suffering from ocular surface pain and related conditions.
Latest Patents
Michael Mutz holds a patent for "Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4H-quinazolin-3-yl)-benzonitrile and formulations thereof." This patent provides polymorphs and formulations of the compound, which is aimed at treating ocular surface pain. The invention also outlines methods for addressing dry eye disease and ocular hyperemia through the administration of this compound.
Career Highlights
Michael Mutz is associated with Bausch + Lomb Ireland Limited, a company renowned for its commitment to eye health. His work at the company has been instrumental in advancing ocular treatment options. With a focus on innovative solutions, he continues to contribute to the field of ophthalmology.
Collaborations
Michael has collaborated with talented coworkers, including Fang Wang and Mei Xia. Their combined expertise has fostered a productive environment for research and development in ocular treatments.
Conclusion
Michael Mutz is a dedicated inventor whose work has the potential to significantly impact the treatment of ocular conditions. His innovative approach and commitment to research exemplify the importance of advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile